We had the pleasure of welcoming Slovak alpine skiing champion Petra Vlhová to our SanaClis...
Team SanaClis attended Fierce JPM Week in January, joining pharma, biopharma and healthcare leaders to shape 2025! With fresh regulations, shifting trends, and evolving industry dynamics, the spotlight was on innovative strategies.
Our VP, John Murray, deep-dived into "Innovative Risk-Sharing Models for Biotech Success", explore cutting-edge strategies that can reshape the future of our industry, providing invaluable insights into:- Performance-Based Models: Share financial risks with clear goals and incentives for strategic alignment.
- Revenue Sharing for Biotech: Support smaller firms and innovative therapies with shared financial burdens and future revenue potential.
- Hybrid Approaches: Combine milestone-based payments with revenue-sharing elements to balance commitment and flexibility.
In case you missed the presentation, feel free to reach out.
It’s with great enthusiasm that we officially announce our landmark partnership between...
SanaClis is honored and grateful to have been awarded the Félix Business Award in the main...